Literature DB >> 848431

Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery disease.

H J Berger, B L Zaret, L Speroff, L S Cohen, S Wolfson.   

Abstract

The relation between myocardial release of prostaglandin and myocardial ischemia was studied in 12 selected patients with multivessel coronary artery disease. These 12 were chosen for analysis because they experienced angina pectoris, ischemic electrocardiographic changes and decreased myocardial lactate uptake during atrial pacing. Simultaneous aortic and coronary sinus blood samples were obtained at rest, during angina and after recovery and were assayed for prostaglandins F, E and A with radioimmunoassay. Cardiac release of prostaglandin F was observed during angina in 11 of 12 patients. Aortic prostaglandin levels remained constant throught each study. During angina, the mean aortovenous difference (+/- standard error) was -0.30 +/- 0.04 ng/ml (P less than 0.001) for prostaglandin F and -0.10 +/- 0.03 ng/ml (Pless than 0.001) for prostaglandin E. There was no significant release of prostaglandin A. Blood samples were also drawn at subanginal heart rates in two patients. Prostaglandin F was released only during angina. In three control patients with a chest pain syndrome and normal coronary arteries, comparable atrial pacing produced no release of prostaglandin F, E or A. These results, together with the known vascular and metabolic actions of prostaglandins, suggest that these pharmacologically active compounds may also play a physiologic role in the cardiac response to ischemia in man.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848431     DOI: 10.1016/s0002-9149(77)80154-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction.

Authors:  J Aznar; M T Santos; J Valles; J Sala
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

Review 2.  [Prostaglandins in cardiovascular and renal function. Biochemical, physiological and clinical findings (author's transl)].

Authors:  P C Weber; W Siess; B Scherer
Journal:  Klin Wochenschr       Date:  1979-05-03

Review 3.  ACE inhibitors for the treatment of myocardial ischemia?

Authors:  C Linder; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

4.  Effect of prostacyclin infusion during low-flow ischaemia in the isolated perfused rat heart.

Authors:  W G Nayler; M Purchase; G J Dusting
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

5.  Endogenous bradykinin activates ischaemically sensitive cardiac visceral afferents through kinin B2 receptors in cats.

Authors:  S C Tjen-A-Looi; H L Pan; J C Longhurst
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

6.  Prostaglandin formation from exogenous precursor in homogenates of human cardiac tissue.

Authors:  R Brandt; J Nowak; T Sonnenfeld
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

7.  Myocardial synthesis of prostaglandin-like substances and coronary reactions to cardiostimulation and to hypoxia.

Authors:  F A Sunahara; J Talesnik
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

8.  Coronary vasodilation: interactions between prostacyclin and adenosine.

Authors:  K E Blass; W Förster; U Zehl
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

9.  Xanthine oxidase, but not neutrophils, contributes to activation of cardiac sympathetic afferents during myocardial ischaemia in cats.

Authors:  Stephanie C Tjen-A-Looi; Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-08-15       Impact factor: 5.182

10.  Possible role of prostaglandins in the regulation of coronary blood flow.

Authors:  K Schrör
Journal:  Basic Res Cardiol       Date:  1981 May-Jun       Impact factor: 17.165

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.